This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovations of Harry Tiemessen
Introduction
Harry Tiemessen is a notable inventor based in Binningen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work with liposomes. His expertise and creativity have led to the development of a unique patent that showcases his skills as an inventor.
Latest Patents
Harry Tiemessen holds a patent for "Allylamine-containing liposomes." This invention represents a significant advancement in the formulation of liposomal drugs, potentially enhancing their efficacy and delivery mechanisms. The patent highlights his ability to innovate within the pharmaceutical industry.
Career Highlights
Tiemessen is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects. His work is instrumental in advancing the company's mission to improve patient outcomes through innovative therapies.
Collaborations
Throughout his career, Harry has worked alongside esteemed colleagues such as David Bodmer and Thomas Kissel. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of new pharmaceutical solutions.
Conclusion
Harry Tiemessen's contributions to the field of pharmaceuticals through his patent and work at Novartis AG exemplify the impact of innovation in healthcare. His dedication to advancing drug delivery systems is commendable and highlights the importance of inventors in shaping the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
